The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Compulsive drug use linked to sensitized ventral striatal dopamine transmission.
Abstract
OBJECTIVE: A small group of Parkinson's disease (PD) patients compulsively use dopaminergic drugs despite causing harmful social, psychological, and physical effects and fulfil core Diagnostic and Statistical Manual (of Mental Disorders) Fourth Edition criteria for substance dependence (dopamine dysregulation syndrome [DDS]). We aimed to evaluate levodopa-induced dopamine neurotransmission in the striatum of patients with DDS compared with PD control patients. METHODS: We used a two-scan positron emission tomography protocol to calculate the percentage change in (11)C-raclopride binding potential from a baseline withdrawal (off drug) state to the binding potential after an oral dose of levodopa. We related the subjective effects of levodopa to the effects on endogenous dopamine release of a pharmacological challenge with levodopa in eight control PD patients and eight patients with DDS. RESULTS: PD patients with DDS exhibited enhanced levodopa-induced ventral striatal dopamine release compared with levodopa-treated patients with PD not compulsively taking dopaminergic drugs. The sensitized ventral striatal dopamine neurotransmission produced by levodopa in these individuals correlated with self-reported compulsive drug "wanting" but not "liking" and was related to heightened psychomotor activation (punding). INTERPRETATION: This provides evidence that links sensitization of ventral striatal circuitry in humans to compulsive drug use.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, it is now increasingly clear that increases of human dopamine do not reliably cause enhancement of subjective ratings of pleasure (although many rewards do induce dopamine release as a consequence and correlate, but not the cause, of pleasure) (Leyton et al., 2002; Evans et al., 2006; Liggins et al., 2012).”
From Evolving Concepts of Emotion and Motivation (2018) · cites this paper as Evans et al., 2006
In the citing paper
“Dopamine surges in nucleus accumbens evoked by addictive amphetamine or by L-DOPA correlate poorly with human subjective liking ratings of the drug - but do control their subjective wanting ratings to take more of that drug (Leyton et al., 2002; Evans et al., 2006).”
From Evolving Concepts of Emotion and Motivation (2018) · cites this paper as Evans et al., 2006
In the citing paper
“Similarly, it is now increasingly clear that increases of human dopamine do not reliably cause enhancement of subjective ratings of pleasure (although many rewards do induce dopamine release as a consequence and correlate, but not the cause, of pleasure) (Leyton et al., 2002; Evans et al., 2006; Liggins et al., 2012).”
From Evolving Concepts of Emotion and Motivation (2018) · cites this paper as Evans et al., 2006
Citations
Cites
Development and validation of brief measures of positive and negative affect: The PANAS scales.
Watson, D., Clark, L. A., & Tellegen, A. (1988) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.54.6.1063 · Cited by 32,433
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Carver, C. S., & White, T. L. (1994) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.67.2.319 · Cited by 7,306
A psychobiological model of temperament and character
Cloninger, C. R. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820240059008 · Cited by 5,458
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
(1994) · Cited by 2,675
Recent Developments in Parkinson's Disease
Hurtig, H. I. (1987) · Neurology · doi:10.1212/wnl.37.5.893 · Cited by 1,925
Behavioral expressions and biosocial bases of sensation seeking
Corr, P. J. (1995) · Personality and Individual Differences · doi:10.1016/0191-8869(95)90059-4 · Cited by 1,525
The psychology and neurobiology of addiction: an incentive–sensitization view
Robinson, T. E., & Berridge, K. C. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.19.x · Cited by 1,507
Cited by
Sorted by citations
The debate over dopamine’s role in reward: the case for incentive salience
Berridge, K. C. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0578-x · Cited by 2,347
Dissecting components of reward: ‘liking’, ‘wanting’, and learning
Berridge, K. C., Robinson, T. E., & Aldridge, J. W. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.014 · Cited by 1,942
Berridge, K. C., & Kringelbach, M. L. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.018 · Cited by 1,730
The incentive sensitization theory of addiction: some current issues
Robinson, T. E., & Berridge, K. C. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0093 · Cited by 1,717
Liking, wanting, and the incentive-sensitization theory of addiction
Berridge, K. C., & Robinson, T. E. (2016) · American Psychologist · doi:10.1037/amp0000059 · Cited by 1,440
Affective neuroscience of pleasure: reward in humans and animals
Berridge, K. C., & Kringelbach, M. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1099-6 · Cited by 1,254
From prediction error to incentive salience: mesolimbic computation of reward motivation.
Berridge, K. C. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.07990.x · Cited by 700
Thobois, S., Ardouin, C., Lhommée, E., Klinger, H., Lagrange, C., Xie, J., Fraix, V., Braga, M.-C. C., Hassani, R., Kistner, A., et al. (2010) · Brain · doi:10.1093/brain/awq032 · Cited by 546
Steeves, T. D. L., Miyasaki, J., Zurowski, M., Lang, A. E., Pellecchia, G., Van Eimeren, T., Rusjan, P., Houle, S., & Strafella, A. P. (2009) · Brain · doi:10.1093/brain/awp054 · Cited by 502
Fineberg, N. A., Chamberlain, S. R., Goudriaan, A. E., Stein, D. J., Vanderschuren, L. J. M. J., Gillan, C. M., Shekar, S., Gorwood, P. A. P. M., Voon, V., Morein-Zamir, S., et al. (2014) · CNS Spectrums · doi:10.1017/s1092852913000801 · Cited by 488
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P., Feyder, M. T., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 492
Parkinson's disease: The quintessential neuropsychiatric disorder
Weintraub, D. A., & Burn, D. J. (2011) · Movement Disorders · doi:10.1002/mds.23664 · Cited by 422
Medication-Related Impulse Control and Repetitive Behaviors in Parkinson Disease
Voon, V., & Fox, S. H. (2007) · Archives of Neurology · doi:10.1001/archneur.64.8.1089 · Cited by 397
Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update
Voon, V., Napier, T. C., Frank, M. J., Sgambato, V., Grace, A. A., Rodríguez‐Oroz, M., Obeso, J. A., Bézard, E., & Fernagut, P. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30004-2 · Cited by 360
Voon, V., Fernagut, P., Wickens, J. R., Baunez, C., Rodríguez-Oroz, M. C., Pavon, N., Juncos, J. L., Obeso, J. A., & Bézard, E. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70287-x · Cited by 365
Natural rewards, neuroplasticity, and non-drug addictions
Olsen, C. M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.03.010 · Cited by 339
Personality, Addiction, Dopamine: Insights from Parkinson's Disease
Dagher, A., & Robbins, T. W. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.031 · Cited by 339
O'Sullivan, S. S., Wu, K., Politis, M., Lawrence, A. D., Evans, A. H., Bose, S. K., Djamshidian, A., Lees, A. J., & Piccini, P. (2011) · Brain · doi:10.1093/brain/awr003 · Cited by 297
Self-citationMechanisms underlying dopamine-mediated reward bias in compulsive behaviors
Voon, V., Pessiglione, M., Brezing, C., Gallea, C., Fernandez, H. H., Dolan, R. J., & Hallett, M. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.027 · Cited by 280
Evolving Concepts of Emotion and Motivation
Berridge, K. C. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.01647 · Cited by 273
O'Hara, C., Campbell, I. C., & Schmidt, U. H. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.02.012 · Cited by 271
Impulse Control and Related Disorders in Parkinson's Disease
Weintraub, D. A., & Claassen, D. O. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.04.006 · Cited by 284
Dopamine Dysregulation Syndrome: An Overview of its Epidemiology, Mechanisms and Management
OʼSullivan, S. S., Evans, A. H., & Lees, A. J. (2009) · CNS Drugs · doi:10.2165/00023210-200923020-00005 · Cited by 265
Self-citationNeuroimaging in Parkinson disease: from research setting to clinical practice
Politis, M. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.205 · Cited by 264
Roles of "wanting" and "liking" in motivating behavior: gambling, food, and drug addictions
Robinson, M. J. F., Fischer, A. M., Ahuja, A., Lesser, E. N., & Maniates, H. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_387 · Cited by 247
Levodopa in the Treatment of Parkinson's Disease: Current Status and New Developments
Salat, D., & TOLOSA, E. S. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130186 · Cited by 243
Behavioral Addictions: An Overview
Karim, R., & Chaudhri, P. (2012) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2012.662859 · Cited by 239
Impulsive and compulsive behaviors in Parkinson's disease
Evans, A. H., Strafella, A. P., Weintraub, D. A., & Stacy, M. A. (2009) · Movement Disorders · doi:10.1002/mds.22505 · Cited by 246
Self-citationNeuropsychiatric effects of subthalamic neurostimulation in Parkinson disease
Volkmann, J., Daniels, C., & Witt, K. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.111 · Cited by 232
Building a neuroscience of pleasure and well-being
Berridge, K. C., & Kringelbach, M. L. (2011) · Psychology of Well-Being: Theory, Research and Practice · doi:10.1186/2211-1522-1-3 · Cited by 229
Gallagher, D. A., O’Sullivan, S. S., Evans, A. H., Lees, A. J., & Schrag, A. E. (2007) · Movement Disorders · doi:10.1002/mds.21611 · Cited by 224
Self-citationRodríguez‐Oroz, M., López‐Azcárate, J., García‐García, D., Alegre, M., Toledo, J. B., Valencia, M., Guridi, J., Artieda, J., & Obeso, J. A. (2010) · Brain · doi:10.1093/brain/awq301 · Cited by 223
Measuring wanting and liking from animals to humans: a systematic review
Pool, E., Sennwald, V., Delplanque, S., Brosch, T., & Sander, D. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.01.006 · Cited by 211
Striatal Dopamine and the Interface between Motivation and Cognition
Aarts, E., van Holstein, M., & Cools, R. (2011) · Frontiers in Psychology · doi:10.3389/fpsyg.2011.00163 · Cited by 211
Calabresi, P., Castrioto, A., Filippo, M. D., & Picconi, B. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70118-2 · Cited by 216
Overview of the Extranigral Aspects of Parkinson Disease
Lim, S., Fox, S. H., & Lang, A. E. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.561 · Cited by 207
Boileau, I., Payer, D., Chugani, B., Lobo, D. S. S., Houle, S., Wilson, A. A., Warsh, J., Kish, S. J., & Zack, M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.163 · Cited by 198
Impulse control disorders in Parkinson's disease
Voon, V., Mehta, A. R., & Hallett, M. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283489687 · Cited by 195
Dopamine and impulse control disorders in Parkinson's disease
Weintraub, D. A. (2009) · Annals of Neurology · doi:10.1002/ana.21454 · Cited by 189
Phasic dopamine release in appetitive behaviors and drug addiction
Wanat, M., Willuhn, I., Clark, J., & Phillips, P. (2009) · Current Drug Abuse Reviewse · doi:10.2174/1874473710902020195 · Cited by 177
Housden, C. R., O’Sullivan, S. S., Joyce, E. M., Lees, A. J., & Roiser, J. P. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.84 · Cited by 183
Self-citationDopamine dysregulation syndrome in Parkinson’s disease: a systematic review of published cases
Warren, N., O’Gorman, C., Lehn, A., & Siskind, D. J. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-315985 · Cited by 178
Imaging biomarkers in Parkinson's disease.
Brooks, D., & Pavese, N. (2011) · Progress in neurobiology · doi:10.1016/j.pneurobio.2011.08.009 · Cited by 163
Self-citationThe nonmotor symptoms of Parkinson's disease—An overview
Lim, S., & Lang, A. E. (2010) · Movement Disorders · doi:10.1002/mds.22786 · Cited by 171
Striatal ups and downs: Their roles in vulnerability to addictions in humans
Leyton, M., & Vezina, P. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.018 · Cited by 165
Giladi, N., Weitzman, N., Schreiber, S., Shabtai, H., & Peretz, C. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106073109 · Cited by 164
Medication-related impulse control and repetitive behaviors in Parkinson??s disease
Voon, V., Potenza, M. N., & Thomsen, T. R. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32826fbc8f · Cited by 162
The Neuropsychiatry of Parkinson Disease: A Perfect Storm
Weintraub, D. A., & Mamikonyan, E. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.03.002 · Cited by 172
Cilia, R., Ko, J. H., Cho, S. S., van Eimeren, T., Marotta, G., Pellecchia, G., Pezzoli, G., Antonini, A., & Strafella, A. P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.013 · Cited by 166
Dopamine and addiction: what have we learned from 40 years of research
Solinas, M., Belujon, P., Fernagut, P., Jaber, M., & Thiriet, N. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1957-2 · Cited by 163
Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease
Merims, D., & Giladi, N. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.09.007 · Cited by 148
A systematic review of impulse control disorders in Parkinson’s disease.
Callesen, M. B., Scheel-Krüger, J., Kringelbach, M. L., & Møller, A. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-120165 · Cited by 130
Compulsive features in behavioural addictions: the case of pathological gambling
el‐Guebaly, N., Mudry, T., Zohar, J., Tavares, H., & Potenza, M. N. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03546.x · Cited by 140
Conditioned and sensitized responses to stimulant drugs in humans
Leyton, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.027 · Cited by 127
“You Say it's Liking, I Say it's Wanting …”. On the difficulty of disentangling food reward in man
Havermans, R. C. (2011) · Appetite · doi:10.1016/j.appet.2011.05.310 · Cited by 125
The Incentive-Sensitization Theory of Addiction 30 Years On
Robinson, T. E., & Berridge, K. C. (2024) · Annual Review of Psychology · doi:10.1146/annurev-psych-011624-024031 · Cited by 146
Ceravolo, R., Frosini, D., Rossi, C. A., & Bonuccelli, U. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70847-8 · Cited by 124
Implicit measures of “wanting” and “liking” in humans
Tibboel, H., Houwer, J. D., & Bockstaele, B. V. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.09.015 · Cited by 130
Dopamine turnover increases in asymptomatic LRRK2 mutations carriers
Sossi, V., de la Fuente‐Fernández, R., Nandhagopal, R., Schulzer, M., McKenzie, J., Ruth, T. J., Aasly, J. O., Farrer, M. J., Wszołek, Z. K., & Stoessl, A. J. (2010) · Movement Disorders · doi:10.1002/mds.23356 · Cited by 119
Can the neuroeconomics revolution revolutionize psychiatry?
Hasler, G. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.011 · Cited by 122
Hedonic Hotspots: Generating Sensory Pleasure in the Brain
Smith, K. S., Mahler, S. V., Peciña, S., & Berridge, K. C. (2009) · Oxford University Press eBooks · doi:10.1093/oso/9780195331028.003.0003 · Cited by 123
Molecular mechanisms underlying levodopa-induced dyskinesia
Calabresi, P., Filippo, M. D., Ghiglieri, V., & Picconi, B. (2008) · Movement Disorders · doi:10.1002/mds.22019 · Cited by 118
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?
Calabresi, P., Ghiglieri, V., Mazzocchetti, P., Corbelli, I., & Picconi, B. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0184 · Cited by 119
Non-dopaminergic treatments in development for Parkinson's disease
Fox, S. H., Brotchie, J. M., & Lang, A. E. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70214-x · Cited by 115
Impulse Control and Related Disorders in Parkinson’s Disease
Weintraub, D. A., & Nirenberg, M. J. (2012) · Neurodegenerative Diseases · doi:10.1159/000341996 · Cited by 113
Ersche, K. D., Bullmore, E. T., Craig, K. J., Shabbir, S. S., Abbott, S., Müller, U., Ooi, C., Suckling, J., Barnes, A., Sahakian, B. J., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.60 · Cited by 108
Impulse Control Disorders in Parkinson's Disease. A Brief and Comprehensive Review
Gatto, E. M., & Aldinio, V. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00351 · Cited by 118
How central is dopamine to pathological gambling or gambling disorder?
Potenza, M. N. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00206 · Cited by 107
Impulsivity and apathy in Parkinson's disease
Sinha, N., Manohar, S., & Husain, M. (2013) · Journal of Neuropsychology · doi:10.1111/jnp.12013 · Cited by 125
Cerebral interactions of pain and reward and their relevance for chronic pain
Becker, S., Gandhi, W., & Schweinhardt, P. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.03.013 · Cited by 103
Decision making, impulsivity, and addictions: Do Parkinson's disease patients jump to conclusions?
Djamshidian, A., O’Sullivan, S. S., Sanotsky, Y., Sharman, S., Matviyenko, Y., Foltynie, T., Michalczuk, R., Avilés-Olmos, I., Fedoryshyn, L., Doherty, K. A., et al. (2012) · Movement Disorders · doi:10.1002/mds.25105 · Cited by 102
Self-citationImpulse Control and Related Disorders in Parkinson's Disease
Lim, S., Evans, A. H., & Miyasaki, J. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1444.006 · Cited by 99
Self-citationImpulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels
Voon, V., Rizos, A., Chakravartty, R., Mulholland, N. J. R., Robinson, S., Howell, N. A., Harrison, N. A., Vivian, G., & Chaudhuri, К. R. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305395 · Cited by 99
Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease
Potenza, M. N., Voon, V., & Weintraub, D. A. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0680 · Cited by 94
Applying incentive sensitization models to behavioral addiction
Thomsen, K. R., Fjorback, L. O., Møller, A., & Lou, H. C. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.07.009 · Cited by 103
Imaging of compensatory mechanisms in Parkinson's disease
Appel‐Cresswell, S., de la Fuente‐Fernández, R., Galley, S., & McKeown, M. J. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32833b6019 · Cited by 92
A linear model for estimation of neurotransmitter response profiles from dynamic PET data
Normandin, M. D., Schiffer, W. K., & Morris, E. D. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.07.002 · Cited by 94
The role of learning-related dopamine signals in addiction vulnerability
Huys, Q. J. M., Tobler, P. N., Hasler, G., & Flagel, S. B. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63425-2.00003-9 · Cited by 92
Management of psychiatric and cognitive complications in Parkinson’s disease
Weintraub, D. A., Aarsland, D., Biundo, R., Dobkin, R. D., Goldman, J. G., & Lewis, S. J. G. (2022) · BMJ · doi:10.1136/bmj-2021-068718 · Cited by 91
Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease
Djamshidian, A., Jha, A., O’Sullivan, S. S., Silveira‐Moriyama, L., Jacobson, C., Brown, P., Lees, A. J., & Averbeck, B. B. (2010) · Movement Disorders · doi:10.1002/mds.23247 · Cited by 90
Self-citationThe prevalence and clinical characteristics of punding in Parkinson's disease
Spencer, A., Rickards, H. E., Fasano, A. A., & Cavanna, A. E. (2011) · Movement Disorders · doi:10.1002/mds.23508 · Cited by 86
Sivanandy, P., Tan, C. L., Xiang, T. C., Ling, T. C., Han, S. A. W., Semilan, S. L. A., & Hong, P. K. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19010364 · Cited by 86
Parkinson’s disease-related disorders in the impulsive-compulsive spectrum
Wolters, E. C., van der Werf, Y. D., & van den Heuvel, O. A. (2008) · Journal of Neurology · doi:10.1007/s00415-008-5010-5 · Cited by 85
Behavioral effects of levodopa
Beaulieu‐Boire, I., & Lang, A. E. (2014) · Movement Disorders · doi:10.1002/mds.26121 · Cited by 83
Amphetamine Sensitization Alters Reward Processing in the Human Striatum and Amygdala
O’Daly, O., Joyce, D. W., Tracy, D. K., Azim, A., Stephan, K. E., Murray, R. M., & Shergill, S. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093955 · Cited by 88
Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease?
Lim, S., Farrell, M. J., Gibson, S. J., Helme, R. D., Lang, A. E., & Evans, A. H. (2008) · Movement Disorders · doi:10.1002/mds.22111 · Cited by 83
Self-citationApathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors
Sierra, M., Carnicella, S., Strafella, A. P., Bichon, A., Lhommée, E., Castrioto, A., Chabardès, S., Thobois, S., & Krack, P. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150535 · Cited by 83
Nonmotor Manifestations in Parkinson Disease
Bernal-Pacheco, Ó., Limotai, N., Go, C. L., & Fernandez, H. H. (2012) · The Neurologist · doi:10.1097/nrl.0b013e31823d7abb · Cited by 84
Janhunen, S. K., & Ahtee, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.09.008 · Cited by 83
Zahodne, L. B., Susatia, F., Bowers, D., Ong, T. L., Jacobson, C. E., Okun, M. S., Rodriguez, R. L., Malaty, I. A., Foote, K. D., & Fernandez, H. H. (2011) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.23.1.56 · Cited by 86
Characteristics of the sequence effect in Parkinson's disease
Kang, S. Y., Wasaka, T., Shamim, E. A., Auh, S., Ueki, Y., Lopez, G. J., Kida, T., Jin, S., Dang, N., & Hallett, M. (2010) · Movement Disorders · doi:10.1002/mds.23251 · Cited by 81
Novelty seeking behaviour in Parkinson's disease
Djamshidian, A., O’Sullivan, S. S., Wittmann, B. C., Lees, A. J., & Averbeck, B. B. (2011) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2011.04.026 · Cited by 81
Self-citationSubstance Abuse and Movement Disorders: Complex Interactions and Comorbidities
Deik, A., Saunders-Pullman, R. J., & Luciano, M. S. (2012) · Current Drug Abuse Reviews · doi:10.2174/1874473711205030243 · Cited by 80
The dopaminergic hypothesis of attention-deficit/hyperactivity disorder needs re-examining
Gonon, F. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.010 · Cited by 79
Oberlin, B. G., Džemidžić, M., Tran, S. M., Soeurt, C. M., Albrecht, D., Yoder, K. K., & Kareken, D. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.91 · Cited by 83
Payer, D. E., Guttman, M., Kish, S. J., Tong, J., Strafella, A. P., Zack, M. H., Adams, J. R., Rusjan, P., Houle, S., Furukawa, Y., et al. (2015) · Movement Disorders · doi:10.1002/mds.26135 · Cited by 78
Dopamine ‘ups and downs’ in addiction revisited
Samaha, A., Khoo, S. Y., Ferrario, C. R., & Robinson, T. E. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.03.003 · Cited by 80
Invited Article: Functional imaging in Parkinson disease
Nandhagopal, R., McKeown, M. J., & Stoessl, A. J. (2008) · Neurology · doi:10.1212/01.wnl.0000310432.92489.90 · Cited by 77
Hypomania and mania related to dopamine replacement therapy in Parkinson's disease
Maier, F., Merkl, J., Ellereit, A. L., Lewis, C. J., Eggers, C., Pedrosa, D. J., Kalbe, E., Kuhn, J., Meyer, T. D., Zurowski, M., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.01.001 · Cited by 76
Dopamine Circuit Mechanisms of Addiction-Like Behaviors
Poisson, C. L., Engel, L., & Saunders, B. T. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.752420 · Cited by 75
Metadata
- Authors
- Evans, A. H., Pavese, N., Lawrence, A. D., Tai, Y. F., Appel, S., Doder, M., Brooks, D. J., Lees, A. J., & Piccini, P.
- Affiliations
- National Hospital for Neurology and Neurosurgery (GB)
- Hammersmith Hospital (GB)
- MRC Cognition and Brain Sciences Unit (GB)
- Corresponding author
- Piccini, Paola
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2006-03-23
- Volume
- 59
- Issue
- 5
- Pages
- 852-858
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2115622614
- Cited by
- 473
- References
- 52
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 11 · 2023: 8 · 2022: 15 · 2021: 17 · 2020: 76 · 2019: 10 · 2018: 25 · 2017: 20 · 2016: 17 · 2015: 30 · 2014: 23 · 2013: 30 · 2012: 30
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- dopamine dysregulation syndrome, compulsive drug use, Parkinson's disease, ventral striatum, dopamine signaling, levodopa challenge, dopamine release, punding, drug liking, substance dependence
- MeSH terms
- Aged, Brain Mapping, Dopamine, Exploratory Behavior, Female, Humans, Levodopa, Male, Middle Aged, Synaptic Transmission, Psychological Tests, Dopamine Agents, Neostriatum, Receptors, Dopamine D2, Dopamine Antagonists, Substance-Related Disorders, Raclopride, Positron-Emission Tomography, Receptors, Dopamine D3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
